Caption Management’s Amedisys AMED Stock Holding History

Caption Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,000	Closed	-$1.49M	–	1566
2021 Q3	$1.49M	Buy	10,000 +8,200	+456%	+$1.7M	0.02%	887
2021 Q2	$440K	Hold	1,800	–	–	0.01%	1071
2021 Q1	$477K	Buy	+1,800	New	+$508K	0.01%	818

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Caption Management's AMED Position: Q4 2021 in Review

Caption Management sold out of Amedisys (AMED) in Q4 2021, closing a stake of 10,000 shares — an estimated $1.49M sold.

Caption Management first reported a position in AMED in Q1 2021 and held it in 3 quarters. The position peaked at $1.49M in Q3 2021. 324 funds tracked by Wall St. Rank hold AMED as of Q4 2021.

Caption Management reported no remaining Amedisys position as of Q4 2021 after selling out during the quarter.
Caption Management sold 10,000 Amedisys shares in Q4 2021, an estimated $1.49M.
Caption Management first reported a position in Amedisys in Q1 2021 and held it in 3 quarters.
Caption Management's Amedisys position peaked at $1.49M in Q3 2021.
324 funds tracked by Wall St. Rank held Amedisys as of Q4 2021.

Based on Caption Management's 13F filing for Q4 2021, filed 11 Feb 2022.